Skip to content

Study to evaluate the effect of continuous use of the test product on muscle mass and body fat

Study to evaluate the effect of continuous use of the test product on muscle mass and body fat - Study to evaluate the effect of continuous use of the test product on muscle mass and body fat

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000041388
Enrollment
40
Registered
2020-08-14
Start date
2020-08-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Use the test product once a week for 30 minutes. Do not use the test product.

Sponsors

IMEQRD Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. 30 to 60 years old (at the time of submission of an informed consent document). 2. Japanese male and female. 3. BMI of over 25 to under 30 4. Those who can input the electronic diary by smart phone or PC. 5. Those who can obtain written consent.

Exclusion criteria

Exclusion criteria: 1. Those who are currently undergoing treatment with some kind of medicine or Chinese herbal medicine (abortive use is acceptable.) 2. Those who have serious liver, kidney, heart, respiratory, endocrine or metabolic diseases. 3. Those who have history of treatment for heart failure, myocardial infarction, etc. 4.Those who are taking diet and exercise therapy under the supervision of a doctor. 5. Those who have a cardiac pacemaker or an implantable medical device placed in the body. 6. Those who have metal in their body due to surgery. 7. Those who have a history of complications of seizure disorders such as epilepsy. 8. Those who have sensory impairment. 9. Those who had a gastrointestinal operation (appendicitis is acceptable.) 10. Those who are taking health food (foods or supplements that affect body composition, or are intended to maintain or restore health). 11. Those who cannot refrain from taking other health foods during the study period. 12. Those who are allergic to drugs or food allergies, and have a current or former illness. 13. Those who consume excessive amounts of alcohol(more than 60g alcohol equivalent/day). 14. Pregnant, lactating, or wanting to become pregnant during the study period. 15. Those who are participating in another clinical trial within one month. 16. Those who were judged to be unsuitable for participation in this study by study investigators or sub-investigators.

Design outcomes

Primary

MeasureTime frame
Visceral fat area, subcutaneous fat area, total fat area, and muscle mass

Secondary

MeasureTime frame
Physical examination (weight, BMI, waist circumference), body fat percentage, basal metabolic rate, and leptin.

Countries

Japan

Contacts

Public ContactHirokuni Kayama

IMEQRD Co., Ltd. Planning and Sales Department

clinical-trial@imeqrd.co.jp03-6704-5968

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026